The Christie NHS Foundation Trust

Specialist MDT: The Christie NHS Foundation Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Low-dose rate brachytherapy
    • High-dose rate brachytherapy
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
    • Clinical trials unit
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling
    • Onco-geriatric service

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here. Please note: the data quality results were amended in May 2022.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 140 140
Performance Status recorded 90% 90%
TNM completed 69% 69%
Stage variable assigned 89% 89%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2019-2020) 153
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 13%
No. of men who received radical prostatectomy (2018) 93
Adjusted percentage of men experiencing at least one GU complication (%) 12%
No. of men who received radical radiotherapy (2018) 324
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 13%

Compare provider outcomes